Longitudinal Changes in Fatigue and Health Status (aims2) in RA Patients Treated With Sc Anti-tnf-alpha Therapy (FARA-study)
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Anti-TNF monoclonal antibodies
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms FARA
- 19 Feb 2015 Biomarkers information updated
- 16 Dec 2013 Planned end date changed from 1 Nov 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 07 Feb 2012 New trial record